Finally, by establishing an afatinib-resistant lung cancer cell line in vitro, HCC827-AR, we further confirmed that BIRC5 was overexpressed in lung adenocarcinoma cell line afatinib resistant cells at the protein levels. The gene discussed is BIRC5; the disease is lung carcinoma.